Biologics in Sjögren's syndrome

C Skarlis, N Marketos, CP Mavragani - Pharmacological Research, 2019 - Elsevier
The use of biologic disease modifying antirheumatic drugs (bDMARDs) in systemic
autoimmune diseases such as rheumatoid arthritis and at a lesser extent in lupus, has been …
被引用次数：9 相关文章

Biologics in Sjögren's syndrome.

C Skarlis, N Marketos, CP Mavragani - Pharmacological Research, 2019 - europepmc.org
The use of biologic disease modifying antirheumatic drugs (bDMARDs) in systemic
autoimmune diseases such as rheumatoid arthritis and at a lesser extent in lupus, has been …

Biologics in Sjögren's syndrome

C Skarlis, N Marketos… - Pharmacological …, 2019 - pubmed.ncbi.nlm.nih.gov
The use of biologic disease modifying antirheumatic drugs (bDMARDs) in systemic
autoimmune diseases such as rheumatoid arthritis and at a lesser extent in lupus, has been …